| 标题 |
A multicenter, randomized, double-blind, phase 2/3 study of ficerafusp alfa (BCA101) or placebo in combination with pembrolizumab for first-line treatment of PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: The FORTIFI-HN01 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:R. Ferrarotto; J. Kaczmar; D. Spigel; Christine H Chung; D. Zandberg; et al 出版日期:2025-06-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)